Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Apr
1
2025
 EC Begins Public Consultation on Upcoming EU Bioeconomy Strategy Bergeson & Campbell, P.C.
Apr
1
2025
 Updates on SB 54: CalRecycle to Take a Second Stab at Implementing Regulations K&L Gates LLP
Apr
1
2025
 A Final Rule Bites the Dust: Federal Court Rules FDA Lacks Authority to Regulate LDTs Epstein Becker & Green, P.C.
Apr
1
2025
 FDA Can’t Stop, Won’t Stop – Navigating the New Administration [Podcast] Keller and Heckman LLP
Apr
1
2025
 We Never Know How High We Are Until We Are Called to Rise: Protecting Alabama’s Medical Cannabis Program Bradley Arant Boult Cummings LLP
Apr
1
2025
 FDA Announces “Operation Stork Speed” Keller and Heckman LLP
Apr
1
2025
 FDA’s New Transparency Tool Addresses Chemical Contaminants Sheppard, Mullin, Richter & Hampton LLP
Mar
31
2025
 New Guidelines Establishing the Requirements and Procedures That Must Be Observed to Obtain Permission to Advertise Prepackaged Food and Non-Alcoholic Beverages OLIVARES
Mar
31
2025
 APHIS Evaluates Petitions Reviewed under 2012 Process, Will Use Process Consistent with USDA Biotechnology Regulations Going Forward Bergeson & Campbell, P.C.
Mar
28
2025
 HHS Job Cuts: FDA, CDC, NIH and CMS Impacted Amidst Significant Restructurings Polsinelli PC
Mar
28
2025
 Nebraska Considers Sales Tax on Candy and Soft Drinks Keller and Heckman LLP
Mar
28
2025
 FDA Announces a “Chemical Contaminants Transparency Tool” to Evaluate Potential Health Risks of Contaminants in Human Foods. Keller and Heckman LLP
Mar
28
2025
 Illinois Moving Forward with BVO Ban Keller and Heckman LLP
Mar
27
2025
 Behavioral Health Law Ledger | March 2025 Greenberg Traurig, LLP
Mar
27
2025
 EPA Extends 2024 RFS Compliance Reporting Deadline Bergeson & Campbell, P.C.
Mar
27
2025
 CLP Changes And What They Mean For Commercial Operations — A Conversation with Karin Baron and Lioba Oerter [Podcast] Bergeson & Campbell, P.C.
Mar
27
2025
 China Releases New Rules Regarding the Use of Facial Recognition Technology Hunton Andrews Kurth
Mar
27
2025
 What’s the (Re)issue? Patent Term Extensions for Reissue Patents McDermott Will & Emery
Mar
27
2025
 China Releases Draft Implementation Measures for the Protection of Drug Trial Data Including Data Exclusivity for Foreign-Originated Drugs Schwegman, Lundberg & Woessner, P.A.
Mar
26
2025
 Ghost Guns and the Bankruptcy Code: Neither Provides Ammunition for Dismissing Actions - SCOTUS Today Epstein Becker & Green, P.C.
Mar
26
2025
 This Week in 340B: March 18 – 24, 2025 McDermott Will & Emery
Mar
25
2025
 DEA Buprenorphine Rule Delayed to December 31, 2025 Foley & Lardner LLP
Mar
25
2025
 Telehealth Cliff Averted, for Now (But September is Six Months Away) Epstein Becker & Green, P.C.
Mar
25
2025
 The End of the Self-Affirmed GRAS Pathway? Epstein Becker & Green, P.C.
Mar
24
2025
 Ex officio interventions by the Anti-Corruption and Good Government Ministry in public tenders in México OLIVARES
Mar
24
2025
 DEA Telemedicine Rules Further Delayed Until (Nearly) 2026 Epstein Becker & Green, P.C.
Mar
24
2025
 The Ketamine Administration Market: A Legal Guide for Healthcare Entities MDRX Law - Sauchik & Giyaur, P.C.
Mar
24
2025
 Federal Circuit Decision Could Encourage More Reissue Patents Foley & Lardner LLP
Displaying 1 - 28 of 12094
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters